R&D Trends

BMS announces global collaboration for immuno-oncology

Wednesday, May 30, 2012 02:43 PM

Global biopharmaceutical company Bristol-Myers Squibb has announced the formation of the International Immuno-Oncology Network (II-ON), a global collaboration between industry and academia that aims to further the scientific understanding of immuno-oncology (harnassing the body’s own immune system to fight cancer).

More... »

Innovative public-private collaboration to tackle antibiotic research

Friday, May 25, 2012 01:05 PM

AstraZeneca and GlaxoSmithKlinehas welcomed the launch of a pioneering approach to antibiotic research in Europe that will see pharmaceutical and biotechnology companies working alongside public partners to tackle the rising threat from antibiotic resistance and address some of the key barriers to the development of effective antibiotics.

More... »

Report: Orphan drug market on the rise

Thursday, May 24, 2012 09:00 AM

GBI Research, a pharmaceutical market expert, has released its report "Orphan Disease Therapeutics Market to 2018: Improved Understanding of Rare Diseases' Heterogeneity and Novel New Clinical Trial Designs to Foster Innovation,” which provides insights into the orphan disease therapeutics market until 2018.

More... »

‘Life Science Panorama 2011’ report looks at France

Wednesday, May 23, 2012 11:13 AM

France Biotech, the French association of life science companies, in partnership with Ernst & Young, published the 10th annual “Life Science Panorama,” describing the industry's main trends for 2010-2011 in France and worldwide.

More... »

Survey raises questions over NHS research

Tuesday, May 22, 2012 11:36 AM

A survey conducted by OnePoll on behalf of the National Institute for Health Research (NIHR) Clinical Research Network raises concerns that patients could be missing out on opportunities to take part in potentially beneficial clinical trials.

More... »

GE Healthcare and Karolinska University to advance cell therapy

Tuesday, May 22, 2012 09:38 AM

Karolinska University Hospital Sweden, one of Europe's largest teaching hospitals, and GE Healthcare Life Sciences have formed a research collaboration to drive advances in technologies and workflows for use in the rapidly emerging field of cell therapy.

More... »

UMass Dartmouth MAB to house biomanufacturing startups

Friday, May 18, 2012 02:26 PM

The University of Massachusetts Dartmouth has broken ground on the site for their new Massachusetts Accelerator for Biomanufacturing (MAB), a facility for startup companies to test biomanufacturing methods and bioproducts located in Fall River, Mass.

More... »

KPCB closes $525 million fund

Friday, May 18, 2012 12:30 PM

Kleiner Perkins Caufield & Byers (KPCB) has successfully closed the KPCB 15, a $525 million venture capital fund focusing on investments in early-stage digital consumer and enterprise, green tech and life sciences companies.

More... »

Obama administration presents national plan to fight Alzheimer’s

Wednesday, May 16, 2012 09:23 AM

Health and Human Services secretary Kathleen Sebelius has released an ambitious national plan to fight Alzheimer’s disease, named “The National Plan to Address Alzheimer’s Disease.”

More... »

ALS TDI, Regenesance partner on Lou Gehrig’s disease

Monday, May 7, 2012 12:35 PM

Cambridge, Mass.-based ALS Therapy Development Institute (ALS TDI), one of the largest ALS drug development centers, has entered into a partnership with Netherlands-based biotech Regenesance to investigate a potential treatment for Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.

More... »